作为前列腺癌的候选治疗标,FGF5的潜在作用
Mary M Stangis1,2, Avan N Colah1,3, Dalton T McLean1
1Department of Urology, University of Wisconsin-Madison Madison, WI, USA.
American journal of clinical and experimental urology
|December 27, 2023
概括
纤维细胞生长因子5 (FGF5) 可能导致前列腺癌和良性前列腺增生. 开发FGF5抑制剂可以为这些与年龄相关的前列腺疾病提供新的治疗方法.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 分子生物学分子生物学
背景情况:
- 纤维细胞生长因子 (FGF) 信号,特别是FGF5,在胚胎发育中至关重要,但随着年龄的增长而下降.
- 在前列腺中,FGF5参与发育,其失调与前列腺癌 (PCa) 有关.
- 有限的研究集中在FGF5在前列腺病理中的特定作用上.
研究的目的:
- 审查FGF5作为前列腺癌 (PCa) 的治疗点的重要性.
- 探索FGF5在良性前列腺增生 (BPH) 中的潜在作用.
- 突出FGF5作为与年龄相关的前列腺疾病的潜在治疗点.
主要方法:
- 在癌症模型中对FGF5功能的文献综述.
- 在前列腺癌发生过程中探索FGF/FGFR信号传递.
- 调查FGF5与良性前列腺增生 (BPH) 之间的潜在联系.
主要成果:
- 在各种癌症模型中,FGF5过度表达与癌症干,转移,扩散和更高的瘤等级有关.
- FGF/FGFR轴与前列腺癌发生有关.
- 建议进一步调查FGF5和BPH之间的潜在联系.
结论:
- FGF5是前列腺癌 (PCa) 和潜在的良性前列腺增生 (BPH) 的重要因素.
- 用抑制剂向FGF5为PCa和BPH提供了一个有希望的治疗策略.
- 新的FGF5抑制剂可以减轻老年男性这些普遍疾病的健康负担.
相关概念视频
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Transducer Mechanism: G Protein–Coupled Receptors
2.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.0K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Small GTPases - Ras and Rho
4.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.0K


